| 1 |
33220025 | Examination of Physiologically-Based Pharmacokinetic Models of Rosuvastatin. | 2021 Jan |
1 |
| 2 |
34415673 | Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model. | 2021 Nov |
2 |
| 3 |
34664206 | Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions. | 2021 Oct |
2 |
| 4 |
35000550 | Assessment of drug-drug interactions of CC-90001, a potent and selective inhibitor of c-Jun N-terminal kinase. | 2021 Dec |
1 |
| 5 |
29719454 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans. | 2018 May |
4 |
| 6 |
28027398 | Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. | 2017 Jul |
2 |
| 7 |
28656677 | Author's response to letter to the editor on: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. | 2017 Oct |
1 |
| 8 |
28656708 | Letter to the Editor, Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. | 2017 Oct |
1 |
| 9 |
21884024 | The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins. | 2012 Oct |
4 |
| 10 |
21717139 | The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. | 2011 Dec |
2 |
| 11 |
18236139 | Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. | 2008 Aug |
3 |